Technology areas: Biotechnology & Pharmaceuticals • Chemistry & Materials • Medical Devices & Mechanical Engineering
6 pending office actions • 5 clients • 5 examiners • 3 art units • 0 of 6 (0%) have an AI response strategy ready
The Grafe Law Office, P.C. operates in Medical Devices & Mechanical Engineering. The firm has 401 career applications. Its resolved allowance rate is 66.26 percent. This rate shows the proportion of resolved applications that result in a patent. For a client, this percentage reflects the frequency of successful outcomes in completed cases.
The firm currently has 4 pending office actions. The average number of office actions per allowance is 3.06. This 3.06 office actions per allowance metric describes the typical interaction frequency with the USPTO. The 401 career applications and 4 pending office actions represent the firm's historical and current portfolio. These data points define the firm's prosecution cycle in its field.
Difficulty is derived from the rejection statutes on the most recent pending office action. §101-driven and multi-statute cases are graded Hard; §112-only and obviousness-type double-patenting cases are graded Easy; everything else is Medium. "Unknown" means we have not yet parsed a statute for that office action.
| Bucket | Cases |
|---|---|
| §103 only | 3 (50%) |
| Double-patenting only | 1 (17%) |
| Multi-statute (no §101) | 2 (33%) |
How the docket's pending cases split across USPTO tech-center bands.
Manual office-action response work runs about 10 hours per case. The time-saved bands below show what IP Author's prosecution pipeline typically delivers — a conservative 20% on the low end, 35% in the middle, 50% on the high end.
| Examiner | Apps on this docket | Allow rate | Interview lift |
|---|---|---|---|
| MENDOZA, WILSON GALLARDO | 2 | 100.0% | +0.0% |
| BRUTUS, JOEL F | 1 | 72.8% | +17.7% |
| RIVERA-CORDERO, ARLYN I | 1 | 63.1% | +27.0% |
| MCCULLOUGH, ERIC J. | 1 | 31.8% | +43.4% |
| BOESEN, CHRISTIAN C | 1 | 75.9% | +21.1% |
Cases in front of an examiner with an allow rate of 80%+ where the difficulty is Easy or Medium. The top 1 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 18751107 | Spiral Element Construction Yielding Enhanced Capacity | MENDOZA, WILSON GALLARDO | — |
Multi-statute / §101-driven matters, or cases in front of an examiner with an allow rate under 30%. The top 2 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19238022 | Cardiac Function Assessment System | BRUTUS, JOEL F | — |
| 18751121 | SPIRAL MEMBRANE ELEMENT TAPERED PROFILE SPACERS | MENDOZA, WILSON GALLARDO | — |
Cases in front of an examiner whose interview lift is 10 percentage points or more — i.e. interviewed cases historically resolve more favorably than non-interviewed ones. The top 4 ordered by deadline are shown.
| App # | Title | Examiner | Due in |
|---|---|---|---|
| 19238022 | Cardiac Function Assessment System | BRUTUS, JOEL F | — |
| 18933032 | Compositions for Engine Carbon Removal from Lubricated Components | RIVERA-CORDERO, ARLYN I | — |
| 18643766 | Spiral Wound Element Construction | MCCULLOUGH, ERIC J. | — |
| 18338233 | Systematic Creation of Fluorescent Fusion Polypeptides | BOESEN, CHRISTIAN C | — |
| Client (Assignee) | Pending OAs |
|---|---|
| Aqua Membranes | 2 |
| MEDICI TECHNOLOGIES, LLC | 1 |
| ATS Chemical | 1 |
| Aqua Membranes In C. | 1 |
| Sandia Biotech, Inc. | 1 |
| Art Unit | Apps |
|---|---|
| 3797 | 1 |
| 1714 | 1 |
| 1684 | 1 |
| App # | Title | Client | Examiner | Art Unit | Statutes | Status | Due in | AI | Filed |
|---|---|---|---|---|---|---|---|---|---|
| 19238022 | Cardiac Function Assessment System | Medici Technologies, LLC | BRUTUS, JOEL F | 3797 | §102§103 | Non-Final OA | — | Pending | Jun 13, 2025 |
| 18933032 | Compositions for Engine Carbon Removal from Lubricated Components | Ats Chemical, LLC | RIVERA-CORDERO, ARLYN I | 1714 | §103 | Final Rejection | — | Pending | Oct 31, 2024 |
| 18751121 | SPIRAL MEMBRANE ELEMENT TAPERED PROFILE SPACERS | Aqua Membranes, Inc. | MENDOZA, WILSON GALLARDO | §103§112 | Non-Final OA | — | Pending | Jun 21, 2024 | |
| 18751107 | Spiral Element Construction Yielding Enhanced Capacity | Aqua Membranes, Inc. | MENDOZA, WILSON GALLARDO | §103 | Non-Final OA | — | Pending | Jun 21, 2024 | |
| 18643766 | Spiral Wound Element Construction | Aqua Membranes In C. | MCCULLOUGH, ERIC J. | §103 | Non-Final OA | — | Pending | Apr 23, 2024 | |
| 18338233 | Systematic Creation of Fluorescent Fusion Polypeptides | Sandia Biotech, Inc. | BOESEN, CHRISTIAN C | 1684 | DP | Non-Final OA | — | Pending | Jun 20, 2023 |
IP Author helps law firms respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.
Start Free Trial